Athersys (ATHX) Jumps After Being Granted FDA Orphan Drug Status

July 9, 2012 2:09 PM EDT Send to a Friend
Athersys, Inc. (Nasdaq: ATHX) spikes on word it was granted FDA orphan drug stats for MPS-1 treatment.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Momentum Movers

Add Your Comment